Opk Biotech LLC
Records under this name other than patents Opk Biotech LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,657,271 | Method of isolating cells from a tissue in a mammal Formerly held Lapsed on the fee record Ended May 23, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 23, 2025 | From the USPTO record |
| US 7,001,715 | Purification of red blood cells by separation and diafiltration Formerly held Term ended Term ended Apr 8, 2023 · From the USPTO record | Term ended | Term ended Apr 8, 2023 | From the USPTO record |
| US 7,553,613 | Use of defibrinated blood for manufacture of hemoglobin-based oxygen carrier Formerly held Lapsed on the fee record Ended Jun 30, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jun 30, 2021 | From the USPTO record |
| US 6,518,010 | Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier Formerly held Term ended Term ended Feb 28, 2021 · From the USPTO record | Term ended | Term ended Feb 28, 2021 | From the USPTO record |
| US 7,459,535 | Method of forming a polymerized hemoglobin solution from stabilized hemoglobin Formerly held Lapsed on the fee record Ended Dec 2, 2020 · From the USPTO record | Lapsed on the fee record | Ended Dec 2, 2020 | From the USPTO record |
| US 7,202,341 | Stabilized hemoglobin solutions Formerly held Lapsed on the fee record Ended Apr 10, 2019 · From the USPTO record | Lapsed on the fee record | Ended Apr 10, 2019 | From the USPTO record |
| US 6,150,507 | Method for producing a purified hemoglobin product Formerly held Term ended Term ended Jul 10, 2018 · From the USPTO record | Term ended | Term ended Jul 10, 2018 | From the USPTO record |
| US 6,133,425 | Acellular red blood cell substitute Formerly held Term ended Term ended Oct 17, 2017 · From the USPTO record | Term ended | Term ended Oct 17, 2017 | From the USPTO record |
| US 7,521,417 | Method and apparatus for preparing an acellular red blood cell substitute Formerly held Term ended Ended no later than Mar 27, 2017 · From the USPTO record | Term ended | Ended no later than Mar 27, 2017 | From the USPTO record |
| US 6,811,778 | Method for improving oxygen transport by stored red blood cells Formerly held Lapsed on the fee record Ended Nov 2, 2016 · From the USPTO record | Lapsed on the fee record | Ended Nov 2, 2016 | From the USPTO record |